| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/07/2002 | EP1227797A2 Solid dispersion pharmaceutical formulations |
| 08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1077981B1 Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same |
| 08/07/2002 | EP1077976B1 Water soluble azoles as broad-spectrum antifungals |
| 08/07/2002 | EP0912097B1 Antimicrobial peroxidase compositions |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0825869B1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | EP0777457B1 Use of glyceryl triacetate for treating onychomycoses |
| 08/07/2002 | EP0764023B1 Compounds and compositions for administration via oral inhalation or insufflation |
| 08/07/2002 | EP0762895B1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 08/07/2002 | CN1362992A Combination neisserial compositions |
| 08/07/2002 | CN1362970A Monoclonal antibody against estrogen-stimulated leucine aminopeptidase |
| 08/07/2002 | CN1362969A Antimicrobial/endotoxin neutralizing polypeptide |
| 08/07/2002 | CN1362966A Pseudomycin amide and ester analogs |
| 08/07/2002 | CN1362964A Novel 8A-and 9A-15-membered lactams |
| 08/07/2002 | CN1362963A 3-deoxy-desmycosin derivatives and process for their preparation |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362887A Endoprosthesis with long-term stability |
| 08/07/2002 | CN1362885A AIDS virus vaccine with use of sendai virus vector |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362875A Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 08/07/2002 | CN1362418A Anticholera vibrio, its toxic chicken yolk antibody and the prepn and application |
| 08/07/2002 | CN1362409A 2-phenoxy pyrimidine derivative and its use in treating disease |
| 08/07/2002 | CN1362261A Health tonic containing rich lucid ganoderma selenium |
| 08/07/2002 | CN1362259A Application of nim extract in medicine |
| 08/07/2002 | CN1362245A Nano medicine for Aucklandiae, coptidis and evodiae and its preparation |
| 08/07/2002 | CN1362243A Nano toxic expelling medicine with five ingredients and its preparation |
| 08/07/2002 | CN1362228A Nano heart fire-clearing away bezoar medicine and its preparation |
| 08/07/2002 | CN1362220A Nano Anemarrhenae, phellodendri and Rehmanniae medicine and its preparation |
| 08/07/2002 | CN1362218A Nano Radix Isatidis medicine and its preparation |
| 08/07/2002 | CN1362212A Nano mixed heartleaf houttuynia herb medicine and its preparation |
| 08/07/2002 | CN1362210A Nano Puerariae, Scutellariae and Coptidis medicine and its preparation |
| 08/07/2002 | CN1362209A Nano bezoar medicine for treating upper respiratory tract infection and its preparation |
| 08/07/2002 | CN1362207A Nano healthy energy restoring agastachis medicine and its preparation |
| 08/07/2002 | CN1362206A Nano Jidesheng sanke bite treating medicine and its preparation |
| 08/07/2002 | CN1362203A Nano cold treating medicine of antelope's horn and its preparation |
| 08/07/2002 | CN1362188A Antiphlogistic honeysuckle flower tablet and its making process |
| 08/07/2002 | CN1362168A Nano resurrecting bezoar medicine and its preparation |
| 08/07/2002 | CN1362162A Nano Niaoganning medicine and its preparation |
| 08/07/2002 | CN1362138A Nano influenza treating decoction and its preparation |
| 08/07/2002 | CN1362133A Nano infantile eczema treating medicine and its preparation |
| 08/07/2002 | CN1362119A Nano natural indigo medicine and its preparation |
| 08/07/2002 | CN1362117A Nano Qili medicine and its preparation |
| 08/07/2002 | CN1362115A Nano Guilin water melon medicine and its preparation |
| 08/07/2002 | CN1362105A Nano Angelicae longhui meidcine and its preparation |
| 08/07/2002 | CN1362092A Biantaoxian'an medicine for treating tonsillitis |
| 08/07/2002 | CN1362091A Nano antiphlogistic bezoar medicine and its preparation |
| 08/07/2002 | CN1362089A Nano sanhuang medicine and its preparation |
| 08/07/2002 | CN1362086A Nano Simiao medicine and its preparation |
| 08/07/2002 | CN1362078A Nano indian chrysanthemum flower medicine and its preparation |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/07/2002 | CN1088598C Culture process of high-yield weak-toxicity distemper cell strain |
| 08/07/2002 | CN1088594C Medicine for anti-tubercle bacillus and preparation process thereof |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429225 For use in therapy of chronic gastritis and gastric ulcer |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428790 Using viricidal polypeptides on solid supports for prophylaxis of human t-cell leukemia/lymphoma virus; antibodies |
| 08/06/2002 | US6428789 Administering antigens obtained from dermatophytes to animals; innoculation; immunology |
| 08/06/2002 | US6428324 Vaccine |
| 08/06/2002 | CA2236223C Natural composition for combatting fungi |
| 08/06/2002 | CA2144327C Transcutaneous in vivo activation of photosensitive agents in blood |
| 08/06/2002 | CA2089368C Antibacterial penem esters derivatives |
| 08/06/2002 | CA1341381C Yeast hybrid vectors and their use for the production of polypeptides |
| 08/01/2002 | WO2002059606A2 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection |
| 08/01/2002 | WO2002059318A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059300A2 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059156A2 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 08/01/2002 | WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | WO2002059148A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | WO2002059146A2 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/01/2002 | WO2002059145A1 Methods for preparing purified lipopeptides |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059123A2 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
| 08/01/2002 | WO2002059116A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 08/01/2002 | WO2002059115A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059104A1 Rustmicin derivatives |
| 08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | WO2002059093A1 Methods and compositions for binding nucleic acid molecules |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | WO2002058789A1 Ocular iontophoretic device and method of use |